Published in Health and Medicine Week, June 1st, 2006
Although the funded research will focus on the production of analogs from the potentially important class of antibiotics called lantibiotics, the technology has broader applications and may also be used for the cost-effective manufacture of a number of commercially important bioactive peptides.
The company has filed a U.S. patent application covering the intellectual property surrounding the DPOLT solid...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week